No Matter What.
Thanks for visiting our team page. This September, BlueRock Therapeutics will once again be joining the Parkinson community across Canada as part of Parkinson Canada SuperWalk.
More than 25 Canadians are diagnosed with Parkinson's every day; more than one person every hour. By 2031, the number of people living with Parkinson’s in Canada will more than double.
As a company, we’re fully committed to a future without Parkinson's. BlueRock Therapeutics is an engineered cell therapy company with a mission to develop regenerative medicines for intractable diseases such as Parkinson's. The FDA has recently granted Fast Track designation for DA01 for advanced Parkinson's disease. DA01, BlueRock's pluripotent stem cell-derived dopaminergic neuron therapy, is under evaluation in a Phase 1 study.
We walk to show our collective support for a united movement of people in communities across Canada looking to make a difference one step at a time.
Help us ensure Parkinson Canada is there for Canadians living with Parkinson’s today – while funding research into better treatments and one day, a cure.
Every dollar raised counts. Thank you for your support!
Click a Name to View Fundraising Page